NT-proBNP、和肽素评估急性冠状动脉综合征病情程度的效果  被引量:1

Study the levels of NT-proBNP、Cop eptin in ACS patients and their relationships with extent of acute coronary syndrome

在线阅读下载全文

作  者:王红艳[1] 张艳霞[1] 

机构地区:[1]河南省济源市人民医院心内科,河南济源450019

出  处:《中国伤残医学》2015年第18期17-19,共3页Chinese Journal of Trauma and Disability Medicine

摘  要:目的:探究血浆N-末端B型脑钠肽( N-terminal pro-B-type natriuretic peptide,NT-proBNP)、和肽素( Copeptin)在急性冠状动脉综合征( acutecoronary syndromes,ACS)不同类型患者中的变化,并探讨与冠状动脉病情严重程度的关系。方法:选取住院并进行冠状动脉造影的ACS患者125例,依照临床诊断标准将ACS患者分为2组,再根据Gensini积分分组进行比对。设冠状动脉正常对照组。所有入选患者于入院当天抽血检测NT-proBNP、Copeptin。结果:(1) ACS 患者两分组NT-proBNP、Copeptin浓度均高于正常对照组,并具有统计学意义(P<0.05);(2)NT-proBNP、Copeptin在ACS患者不同冠状动脉病变程度组间具有统计学意义( P <0.05)。结论:ACS患者的NT-proBNP Copeptin显著高于正常对照组,并且与冠状动脉病变的轻重程度有关;NT-proBNP、Copeptin可作为临床上评价ACS患者病情危险程度实效性的指标。Objective:To explore the diversity of levels of N-terminal pro-B-type natriuretic peptide( NT-proBNP)、Copeptin in patients with acute coronary syndrome( ACS) , and to assess their clinical value.Methods:A total of 125 patients of ACS admitted were divided into three clinical types.These patients were also evaluated by Gensini score for a decision of coronary angiography( CAG) after admission, and divided into three sub-groups.normal volunteers were designated as control groups.The venous blood samples were taken from the patients immediately after admission for detection of NT-proBNP,Copeptin.Results:①Significant differences in NT-proBNP、Copeptin were found between ACS group including the different clinical subgroups and normal group (P〈0.05).②Significant differences in NTproBNP、Copeptin were found among two ACS sub-groups which were divided according to the severity of in patients with coronary artery disease (P〈0.05).Conclusion:There was a correlation between levels of NT-proBNP、Copeptin and different ex-tent of coronary artery lesions in ACS patients.Combined detection of NT-proBNP、Copeptin can be helpful and effective for risk stratifi-cation of the hospitalized patients with ACS after admission.

关 键 词:急性冠脉综合征 N-末端脑利钠肽前体 和肽素 

分 类 号:R543[医药卫生—心血管疾病]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象